Skip to main content

Advertisement

SpringerLink
Log in

New concepts in understanding genital herpes

  • Published:
Current Infectious Disease Reports Aims and scope Submit manuscript

Abstract

Herpes simplex virus (HSV)-2 is a lifelong infection that causes recurrent genital ulcers and, rarely, disseminated and visceral disease. HSV-1 infection is an increasingly important cause of genital ulcers. HSV infections are the most common cause of genital ulcers in adults, but acquisition and chronic infection are more commonly asymptomatic than symptomatic. Both the symptomatic and asymptomatic forms of HSV are of clinical consequence for several reasons. HSV-2 infection enhances HIV-1 acquisition and transmission. In addition, sexual and perinatal transmission can occur during asymptomatic viral shedding. Perinatal transmission is of particular concern because neonatal HSV infection results in severe morbidity to the newborn. Antiviral medicines are effective for limiting recurrence duration and decreasing transmission likelihood, although no available intervention completely prevents transmission. This fact highlights the importance of laboratory diagnostics for this lifelong infection, and the need for an HSV vaccine.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

  1. Xu F, Sternberg M, Kottiri B, et al.: Trends in herpes simplex virus type 1 and type 2 seroprevalence in the United States. JAMA 2006, 296:964–973.

    Article  CAS  PubMed  Google Scholar 

  2. Langenberg AG, Corey L, Ashley RL, et al.: A prospective study of new infections with herpes simplex virus type 1 and type 2. Chiron HSV Vaccine Study Group. N Engl J Med 1999, 341:1432–1438.

    Article  CAS  PubMed  Google Scholar 

  3. Wald A, Zeh J, Selke S, et al.: Reactivation of genital herpes simplex virus type 2 infection in asymptomatic seropositive persons. N Engl J Med 2000, 342:844–850.

    Article  CAS  PubMed  Google Scholar 

  4. Mark KE, Wald A, Magaret AS, et al.: Rapidly cleared episodes of herpes simplex virus reactivation in immunocompetent adults. J Infect Dis 2008, 198:1141–1149.

    Article  PubMed  Google Scholar 

  5. Wald A, Zeh J, Barnum G, Davis L, Corey L: Suppression of subclinical shedding of herpes simplex virus type 2 with acyclovir. Ann Intern Med 1996, 124(1 Pt 1):8–15.

    Google Scholar 

  6. Mertz GJ, Schmidt O, Jourden JL, et al.: Frequency of acquisition of first-episode genital infection with herpes simplex virus from symptomatic and asymptomatic source contacts. Sex Transm Dis 1985, 12:33–39.

    CAS  PubMed  Google Scholar 

  7. Zhu J, Koelle D, Cao J, et al.: Virus-specific CD8+ T cells accumulate near sensory nerve endings in genital skin during subclinical HSV-2 reactivation. J Exp Med 2007, 204:595–603.

    Article  CAS  PubMed  Google Scholar 

  8. Freeman E, Weiss H, Glynn J, et al.: Herpes simplex virus 2 infection increases HIV acquisition in men and women: systematic review and meta-analysis of longitudinal studies. AIDS 2006, 20:73–83.

    Article  PubMed  Google Scholar 

  9. Gray R, Wawer M, Brookmeyer R, et al.: Probability of HIV-1 transmission per coital act in monogamous, heterosexual, HIV-1-discordant couples in Rakai, Uganda. Lancet 2001, 357:1149–1153.

    Article  CAS  PubMed  Google Scholar 

  10. Corey L, Benedetti J, Critchlow C, et al.: Treatment of primary first-episode genital herpes simplex virus infections with acyclovir: results of topical, intravenous and oral therapy. J Antimicrob Chemother 1983, 12(Suppl B):79–88.

    Google Scholar 

  11. Douglas JM, Critchlow C, Benedetti J, et al.: A double-blind study of oral acyclovir for suppression of recurrences of genital herpes simplex virus infection. N Engl J Med 1984, 310:1551–1556.

    CAS  PubMed  Google Scholar 

  12. Corey L, Wald A, Patel R, et al.: Once-daily valacyclovir to reduce the risk of transmission of genital herpes. N Engl J Med 2004, 350:11–20.

    Article  CAS  PubMed  Google Scholar 

  13. Wald A, Langenberg A, Krantz E, et al.: The relationship between condom use and herpes simplex virus acquisition. Ann Intern Med 2005, 143:707–713.

    PubMed  Google Scholar 

  14. Wald A, Langenberg A, Link K, et al.: Effect of condoms on reducing the transmission of herpes simplex virus type 2 from men to women. JAMA 2001, 285:3100–3106.

    Article  CAS  PubMed  Google Scholar 

  15. Weiss H: Epidemiology of herpes simplex virus type 2 infection in the developing world. Herpes 2004, 11(Suppl 1):24A–35A.

    Google Scholar 

  16. Vyse AJ, Gay NJ, Slomka MJ, et al.: The burden of infection with HSV-1 and HSV-2 in England and Wales: implications for the changing epidemiology of genital herpes. Sex Transm Infect 2000, 76:183–187.

    Article  CAS  PubMed  Google Scholar 

  17. Cherpes TL, Meyn LA, Krohn MA, Hillier SL: Risk factors for infection with herpes simplex virus type 2: role of smoking, douching, uncircumcised males, and vaginal flora. Sex Transm Dis 2003, 30:405–410.

    Article  PubMed  Google Scholar 

  18. Gottlieb S, Douglas JJ, Foster M, et al.: Incidence of herpes simplex virus type 2 infection in 5 sexually transmitted disease (STD) clinics and the effect of HIV/STD risk-reduction counseling. J Infect Dis 2004, 190:1059–1067.

    Article  PubMed  Google Scholar 

  19. Brown E, Wald A, Hughes J, et al.: High risk of human immunodeficiency virus in men who have sex with men with herpes simplex virus type 2 in the EXPLORE study. Am J Epidemiol 2006, 164:733–741.

    Article  CAS  PubMed  Google Scholar 

  20. Stanberry LR, Spruance SL, Cunningham AL, et al.: Glycoprotein-D-adjuvant vaccine to prevent genital herpes. N Engl J Med 2002, 347:1652–1661.

    Article  CAS  PubMed  Google Scholar 

  21. Wald A, Huang ML, Carrell D, et al.: Polymerase chain reaction for detection of herpes simplex virus (HSV) DNA on mucosal surfaces: comparison with HSV isolation in cell culture. J Infect Dis 2003, 188:1345–1351.

    Article  CAS  PubMed  Google Scholar 

  22. Brown ZA, Benedetti J, Ashley R, et al.: Neonatal herpes simplex virus infection in relation to asymptomatic maternal infection at the time of labor. N Engl J Med 1991, 324:1247–1252.

    Article  CAS  PubMed  Google Scholar 

  23. Wang K, Lau T, Morales M, et al.: Laser-capture microdis-section: refining estimates of the quantity and distribution of latent herpes simplex virus 1 and varicella-zoster virus DNA in human trigeminal ganglia at the single-cell level. J Virol 2005, 79:14079–14087.

    Article  CAS  PubMed  Google Scholar 

  24. Johnston C, Magaret A, Selke S, et al.: Herpes simplex virus viremia during primary genital infection. J Infect Dis 2008, 198:31–34.

    Article  PubMed  Google Scholar 

  25. Liu T, Khanna K, Carriere B, Hendricks R: Gamma interferon can prevent herpes simplex virus type 1 reactivation from latency in sensory neurons. J Virol 2001, 75:11178–11184.

    Article  CAS  PubMed  Google Scholar 

  26. Crespi C, Cumberland W, Wald A, et al.: Longitudinal study of herpes simplex virus type 2 infection using viral dynamic modelling. Sex Transm Infect 2007, 83:359–364.

    Article  PubMed  Google Scholar 

  27. Koelle D, Liu Z, McClurkan C, et al.: Expression of cutaneous lymphocyte-associated antigen by CD8(+) T cells specific for a skin-tropic virus. J Clin Invest 2002, 110:537–548.

    CAS  PubMed  Google Scholar 

  28. Zhu J, Hladik F, Woodward A, et al.: Persistence of HIV-1 receptor-positive cells after HSV-2 reactivation is a potential mechanism for increased HIV-1 acquisition. Nat Med 2009, 15:886–892.

    Article  CAS  PubMed  Google Scholar 

  29. Bernstein D, Lovett M, Bryson Y: Serologic analysis of first-episode nonprimary genital herpes simplex virus infection. Presence of type 2 antibody in acute serum samples. Am J Med 1984, 77:1055–1060.

    Article  CAS  PubMed  Google Scholar 

  30. Corey L, Adams HG, Brown ZA, Holmes KK: Genital herpes simplex virus infections: clinical manifestations, course, and complications. Ann Intern Med 1983, 98:958–972.

    CAS  PubMed  Google Scholar 

  31. Goodell SE, Quinn TC, Mkrtichian E, et al.: Herpes simplex virus proctitis in homosexual men. Clinical, sigmoidoscopic, and histopathological features. N Engl J Med 1983, 308:868–871.

    Article  CAS  PubMed  Google Scholar 

  32. Benedetti J, Corey L, Ashley R: Recurrence rates in genital herpes after symptomatic first-episode infection. Ann Intern Med 1994, 121:847–954.

    CAS  PubMed  Google Scholar 

  33. Engelberg R, Carrell D, Krantz E, et al.: Natural history of genital herpes simplex virus type 1 infection. Sex Transm Dis 2003, 30:174–177.

    Article  PubMed  Google Scholar 

  34. Schlesinger Y, Tebas P, Gaudreault-Keener M, et al.: Herpes simplex virus type 2 meningitis in the absence of genital lesions: improved recognition with use of the polymerase chain reaction. Clin Infect Dis 1995, 20:842–848.

    CAS  PubMed  Google Scholar 

  35. Liesegang TJ, Melton LJ 3rd, Daly PJ, Ilstrup DM: Epidemiology of ocular herpes simplex. Incidence in Rochester, Minn, 1950 through 1982. Arch Ophthalmol 1989, 107:1155–1159.

    CAS  PubMed  Google Scholar 

  36. Morse SA, Trees DL, Htun Y, et al.: Comparison of clinical diagnosis and standard laboratory and molecular methods for the diagnosis of genital ulcer disease in Lesotho: association with human immunodeficiency virus infection. J Infect Dis 1997, 175:583–589.

    CAS  PubMed  Google Scholar 

  37. Martins TB, Woolstenhulme RD, Jaskowski TD, et al.: Comparison of four enzyme immunoassays with a western blot assay for the determination of type-specific antibodies to herpes simplex virus. Am J Clin Pathol 2001, 115:272–277.

    Article  CAS  PubMed  Google Scholar 

  38. US Centers for Disease Control and Prevention: Diseases characterized by genital ulcers. Available at http://www.cdc.gov/std/treatment/2006/genital-ulcers.htm#genulc3. Accessed June 2009.

  39. Safrin S, Crumpacker C, Chatis P, et al.: A controlled trial comparing foscarnet with vidarabine for acyclovir-resistant mucocutaneous herpes simplex in the acquired immunodeficiency syndrome. The AIDS Clinical Trials Group. N Engl J Med 1991, 325:551–555.

    Article  CAS  PubMed  Google Scholar 

  40. Mendel DB, Barkhimer DB, Chen MS: Biochemical basis for increased susceptibility to Cidofovir of herpes simplex viruses with altered or deficient thymidine kinase activity. Antimicrob Agents Chemother 1995, 39:2120–2122.

    CAS  PubMed  Google Scholar 

  41. Wald A, Krantz E, Selke S, et al.: Knowledge of partners’ genital herpes protects against herpes simplex virus type 2 acquisition. J Infect Dis 2006, 194:42–52.

    Article  PubMed  Google Scholar 

  42. Kobbermann T, Clark L, Griffin WT: Maternal death secondary to disseminated herpesvirus hominis. Am J Obstet Gynecol 1980, 137:742–743.

    CAS  PubMed  Google Scholar 

  43. Whitley RJ, Nahmias AJ, Visintine AM, et al.: The natural history of herpes simplex virus infection of mother and newborn. Pediatrics 1980, 66:489–494.

    CAS  PubMed  Google Scholar 

  44. Brown ZA, Selke S, Zeh J, et al.: The acquisition of herpes simplex virus during pregnancy. N Engl J Med 1997, 337:509–515.

    Article  CAS  PubMed  Google Scholar 

  45. Kropp R, Wong T, Cormier L, et al.: Neonatal herpes simplex virus infections in Canada: results of a 3-year national prospective study. Pediatrics 2006, 117:1955–1962.

    Article  PubMed  Google Scholar 

  46. Brown EL, Gardella C, Malm G, et al.: Effect of maternal herpes simplex virus (HSV) serostatus and HSV type on risk of neonatal herpes. Acta Obstet Gynecol Scand 2007, 86:523–529.

    Article  PubMed  Google Scholar 

  47. Abu-Raddad L, Magaret A, Celum C, et al.: Genital herpes has played a more important role than any other sexually transmitted infection in driving HIV prevalence in Africa. PLoS ONE 2008, 3:e2230.

    Article  PubMed  CAS  Google Scholar 

  48. Morris M, Kretzschmar M: Concurrent partnerships and the spread of HIV. AIDS 1997, 11:641–648.

    Article  CAS  PubMed  Google Scholar 

  49. Drake A, John-Stewart G, Wald A, et al.: Herpes simplex virus type 2 and risk of intrapartum human immunodeficiency virus transmission. Obstet Gynecol 2007, 109(2 Pt 1):403–409.

    Google Scholar 

  50. Schacker T, Zeh J, Hu H, et al.: Changes in plasma human immunodeficiency virus type 1 RNA associated with herpes simplex virus reactivation and suppression. J Infect Dis 2002, 186:1718–1725.

    Article  PubMed  Google Scholar 

  51. Nagot N, Ouédraogo A, Foulongne V, et al.: Reduction of HIV-1 RNA levels with therapy to suppress herpes simplex virus. N Engl J Med 2007, 356:790–799.

    Article  CAS  PubMed  Google Scholar 

  52. Celum C, Wald A, Hughes J, et al.: Effect of acyclovir on HIV-1 acquisition in herpes simplex virus 2 seropositive women and men who have sex with men: a randomised, double-blind, placebo-controlled trial. Lancet 2008, 371:2109–2119.

    Article  CAS  PubMed  Google Scholar 

  53. Watson-Jones D, Weiss HA, Rusizoka M, et al.: Effect of herpes simplex suppression on incidence of HIV among women in Tanzania. N Engl J Med 2008, 358:1560–1571.

    Article  CAS  PubMed  Google Scholar 

  54. Celum C, Wald A, Lingappa J, et al.: Twice-daily acyclovir to reduce HIV-1 transmission from HIV-1 / HSV-2 co-infected persons within HIV-1 serodiscordant couples: a randomized, double-blind, placebo-controlled trial [abstract WELBC101]. Presented at the Fifth International AIDS Society Conference on HIV Pathogenesis, Treatment, and Prevention. Cape Town, South Africa; July 19–22, 2009.

  55. Lisco A, Vanpouille C, Tchesnokov EP, et al.: Acyclovir is activated into a HIV-1 reverse transcriptase inhibitor in herpesvirus-infected human tissues. Cell Host Microbe 2008, 4:260–270.

    Article  CAS  PubMed  Google Scholar 

  56. McMahon MA, Siliciano JD, Lai J, et al.: The antiherpetic drug acyclovir inhibits HIV replication and selects the V75I reverse transcriptase multidrug resistance mutation. J Biol Chem 2008, 283:31289–31293.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Fred Hutchinson Cancer Research Center, Vaccine and Infectious Disease Institute and Program in Infectious Diseases, 1616 Eastlake Avenue, LE-500, Seattle, WA, 98102, USA

    Joshua T. Schiffer

Authors
  1. Joshua T. Schiffer
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Lawrence Corey
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Joshua T. Schiffer.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Schiffer, J.T., Corey, L. New concepts in understanding genital herpes. Curr Infect Dis Rep 11, 457–464 (2009). https://doi.org/10.1007/s11908-009-0066-7

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11908-009-0066-7

Keywords

Search

Navigation